The burgeoning popularity of semaglutide , initially for blood sugar control , is creating significant interest within the British Isles, prompting a notable shift in hormone trends. Availability these compounds remains a complex challenge , with public healthcare system coverage currently limited and specialist practices offering prescriptions at